title: Marginal organs: how far should we go?
authors.affiliation: Department of Nephrology, Klinikum rechts der Isar der, Technischen Universität München, Ismaninger Str. 22, 81675 München, Germany. uwe.heemann@lrz.tum.de
authors.forename: Uwe
authors.initials: U
authors.lastname: Heemann
mesh_terms: D000368:Aged; D002292:Carcinoma, Renal Cell / Q000628:therapy*; D006085:Graft Survival; D006801:Humans; D007680:Kidney Neoplasms / Q000628:therapy*; D008875:Middle Aged; D009369:Neoplasms / Q000209:etiology*; D016377:Organ Transplantation / Q000009:adverse effects* / Q000379:methods*; D013997:Time Factors; D014019:Tissue Donors; D009927:Tissue and Organ Procurement; D016896:Treatment Outcome